U.S. Rep. Clyburn Explains How Clinical Trials Provide Opportunity to Address Health Disparities

Decrease Font Size Increase Font Size Text Size Print This Page

PhRMA: 9/10/13

As you may know from a previous Catalyst post, late last month we unveiled a new report on “Research in Your Backyard: Pharmaceutical Clinical Trials in South Carolina”.

We were honored to be joined by U.S. Representative James E. Clyburn who addressed the importance of clinical trials to making new medicines available to patients, and how the participation of minority patients in clinical trials is necessary to reduce health disparities.  We agree, which is why PhRMA has joined with the National Minority Quality Forum and Microsoft to launch a campaign to encourage greater diversity of patients who volunteer to participate in clinical trials.

The Congressman elaborated on his remarks in a letter to the editor which ran in The Post and Courier on August 30th, and has given us permission to share it. Read more

Share the Clinical Trial Engagement Network


National Minority Quality Forum
1201 15th Street, NW
Suite 340
Washington, DC 20005


Tel: 202.223.7560
Fax: 202.223.7567

Terms of Use     l    Privacy Policy